In the treatment modality of IR combined with chemotherapeutic agents, such as cisplatin or etoposide, GSDME significantly mediates cell pyroptosis, and this combination therapy enhances the immune response to the tumor by increasing the radiosensitivity of the tumor cells concomitantly with significantly enhanced tumor suppression [263]. The gene discussed is GSDME; the disease is neoplasm.